Holen Sie sich die Stockscreener-App
0.233
2.10%
-0.005
Handel nachbörslich:
.24
0.007
+3.00%
Schlusskurs vom Vortag:
$0.238
Offen:
$0.2416
24-Stunden-Volumen:
1.56M
Relative Volume:
0.20
Marktkapitalisierung:
$9.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.58M
KGV:
-1.2574
EPS:
-0.1853
Netto-Cashflow:
$-10.38M
1W Leistung:
+0.34%
1M Leistung:
-38.03%
6M Leistung:
-88.32%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.2313
$0.249
1-Wochen-Bereich:
$0.2301
$0.27
52-Wochen-Spanne:
$0.21
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Firmenname
Liminatus Pharma Inc
Sektor
Branche
Telefon
213-273-5453
Adresse
6 CENTERPOINTE DR., LA PALMA
Compare LIMN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.233 | 9.36M | 0 | -2.58M | -10.38M | -0.1853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Liminatus Pharma Inc Aktie (LIMN) Neueste Nachrichten
Aug Movers: Is Liminatus Pharma Inc stock a top performer YTD2026 Trends & Smart Money Movement Tracker - baoquankhu1.vn
Reviewing Athira Pharma (NASDAQ:LONA) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Insider Trends: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestWeekly Trade Recap & Reliable Volume Spike Alerts - baoquankhu1.vn
Aug Mood: Is Liminatus Pharma Inc a strong growth stock2026 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
How Liminatus Pharma Inc. stock responds to policy changesQuarterly Earnings Report & Expert Curated Trade Setup Alerts - Naître et grandir
Winners Losers: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestJuly 2025 Drop Watch & Weekly Momentum Picks - baoquankhu1.vn
Liminatus Pharma Lowers Quorum Requirement in Bylaw Amendment - TipRanks
Aug Update: Is Liminatus Pharma Inc stock a smart retirement pickJuly 2025 Retail & Reliable Entry Point Trade Alerts - baoquankhu1.vn
LIMN Earnings History & Surprises | EPS & Revenue Results | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
LIMN Should I Buy - Intellectia AI
Basic earnings per share (basic EPS) of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
LIMN PE Ratio & Valuation, Is LIMN Overvalued - Intellectia AI
Free float of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Critical Analysis: Liminatus Pharma (NASDAQ:LIMN) and Athira Pharma (NASDAQ:LONA) - Defense World
Net income of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Dividends – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation - The Ames Tribune
Aug EndMonth: What are Liminatus Pharma Incs recent SEC filings showingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Earnings Risk: What are Liminatus Pharma Incs recent SEC filings showing2025 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Can Liminatus Pharma Inc. Equity Warrant stock deliver strong Q4 earnings2025 Historical Comparison & AI Forecast Swing Trade Picks - mfd.ru
Trend Recap: What is QSIAWs valuation compared to sectorProfit Target & High Conviction Investment Ideas - baoquankhu1.vn
Liminatus Pharma Completes $4 Million Public Equity Offering - TipRanks
Liminatus Pharma Prices $0.29 Equity Offering, Nets $3.46 Million Under Securities Purchase Pact - TradingView
Aug Highlights: Can Liminatus Pharma Inc Equity Warrant be recession proofJuly 2025 Short Interest & Verified Stock Trade Ideas - baoquankhu1.vn
Liminatus Pharma prices $4 million public offering at $0.29 per share - Investing.com India
Liminatus Pharma prices 13.8M shares at 29c in public offering - TipRanks
Gold Down 3%; Medtronic Earnings Top Views - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering - Bitget
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times
Bond Watch: What dividend growth rate does Sun Communities Inc offerWeekly Market Report & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
History Review: Is MasterBrand Inc benefiting from interest rate changesPortfolio Growth Summary & Accurate Intraday Trade Tips - baoquankhu1.vn
Is Liminatus Pharma Inc. Equity Warrant subject to activist investor interestTrade Volume Report & Long-Term Investment Growth Plans - mfd.ru
Published on: 2026-02-15 22:28:13 - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant be recession proofTake Profit & Safe Capital Investment Plans - mfd.ru
Why Liminatus Pharma Inc. Equity Warrant stock is recommended by analysts2025 Market Overview & AI Driven Price Predictions - mfd.ru
Bond Watch: Can Xtant Medical Holdings Inc. (XMS) stock withstand sector downturnsJuly 2025 Volume & Long Hold Capital Preservation Tips - mfd.ru
Is WisdomTree Europe Hedged Equity Fund stock among top earnings playsJuly 2025 Price Swings & Comprehensive Market Scan Reports - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant stock maintain growth trajectoryJuly 2025 Update & High Accuracy Trade Signal Alerts - mfd.ru
LIMN Technical Analysis & Stock Price Forecast - Intellectia AI
How do insiders feel about Liminatus Pharma Inc.Quarterly Profit Review & AI Enhanced Trading Signals - mfd.ru
Why Liminatus Pharma Inc. Equity Warrant stock attracts global investorsJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - mfd.ru
Can Liminatus Pharma Inc. Equity Warrant outperform under higher oil prices2025 Retail Activity & Daily Market Momentum Tracking - mfd.ru
LIMN Liminatus Pharma (NASDAQ) pre-market +15% Feb 12 2026: earnings preview - Meyka
What are Liminatus Pharma Inc.’s recent SEC filings showingWeekly Trend Report & Free Weekly Chart Analysis and Trade Guides - mfd.ru
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Can Liminatus Pharma Inc. Equity Warrant reach resistance levels soon2025 Biggest Moves & Daily Profit Maximizing Tips - mfd.ru
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Highs Report: Is Liminatus Pharma Inc Equity Warrant stock showing strong momentumJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - baoquankhu1.vn
LIMN down 26.83% intraday: Liminatus Pharma (NASDAQ) 09 Feb 2026 earnings ahead - Meyka
Liminatus Pharma Settles Litigation Through Equity Issuance - TipRanks
Finanzdaten der Liminatus Pharma Inc-Aktie (LIMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):